Getting to know Stephen Hahn, M.D.

In February, Stephen Hahn, M.D., was named MD Anderson’s deputy president and chief operating officer. In this role, he’s responsible for day-to-day management of the institution, ensuring excellence across all business, clinical and faculty matters. Hahn joined MD Anderson in 2015 as division head, department chair and professor of Radiation Oncology. Prior to that, he served as chair of the Radiation Oncology department the University of Pennsylvania’s Perelman School of Medicine from 2005 to 2014. As a radiation oncologist, Hahn specializes in treating both lung cancer and sarcoma. His research focuses on the molecular causes of the tumor microenvironment, particularly the study of chemical signals that go awry (known as aberrant signal transduction pathways), and the evaluation of proton therapy as a means to improve the efficiency of radiation therapy. We recently sat down with Hahn to learn a little more about him. Here’s what he had to say. What word best describes you? Energetic. What brought you to MD Anderson? I got the opportunity to lead the Radiation Oncology division at the world’s No. 1 cancer center, where there was a great culture and environment for patient care. What made you go into oncology? I’ve always had an interest in cancer. What prepared you for your role? I served as chair for nine years at the University of Pennsylvania and was on the practice plan and finance committees. What was your first job? I served ice cream at Friendly’s (a chain of ice cream shops based in the Northeast). What do you most enjoy away from work? Working out and spending time with my wife, Lota, and my four...